INVESTOR ALERT - TRTC Revenues Stock- Price !! INVESTOR

New Post Public Reply Private Reply Replies (0) Message Board
cb11
INVESTOR ALERT - TRTC Revenues Stock- Price !!

INVESTOR ALARM ( Ver. Sept. 9th )



Bio·Vegetable & Marijuana-Hemp & Green Tech - TRTC Terra Tech Corp. - USA

( Also Medical Field )



This as attempt for by mutual consent and systematical manner

All Here once to be Agree on same Revenues or Stock- Price

Estimate numbers, because everybody just coming- up with

something different is only causing confusions and really

nothing for the GOOD we need to Relay On !





1. Up-Front lets be Agree on the Stock EPS- Ratios & Earning Definition :

- Blue- Chips have an EPS- Ratio of 10 - 20x , OK !

- None Blue- Chips have an EPS- Ratio of 30 - 60x , OK !

- TRTC as No Blue- Chip to apply middle EPS- Ration of 45x !

- TRTC Stocks instead as Issued & Outstanding 88 Mn take 100 Mn !

( OTC Markets Registered Free- Floating Stocks of 48 Mn, same as 2012 )

- Revenue is Not Earning and Earning is the Margin Not Net- Income

and Net- Income Is after Deductions of Any Expenses from Earning

and before of Any Taxes !





2. For Annual Revenues & Earning to calculate we have TRTC Information’s as :



- 5-Acre Production Plant Revenue $ 10 Mn - we apply 9 Mn by Margin 40 % !

( This also as model to sell High- Tech Companies to US Farming Industry. )



- Contracts with NB Plants of 100% & GroRite of 50% From Its Productions !

NB & GroRite Contracts grant TRTC a Royalty of 10% from its Revenues,

the complain send TRTC to increase this to at least 20% since any Agency

Royalty Standards are between 30 - 60% depending on Items- Price Range.

Wondering when the Vande Vredes will be more reasonable to allow the

Royalty of 20%, but resulting we now need to calculate by 10% only.

From NB Plants is known Revenues $ 6 Mn and GroRite $ 4 Mn, by the

Contracts % Resulting to $ 8 Mn, but we take $ 7 Mn to calculate !



- We have now the Starting Q2 of 65 Days Edible Garden Corp. participation

resulting to $ 0,665 Mn, taking this for the Quarters of usually 90 Days

would result to $ 0,920 Mn, but until now we have no TRTC reply of why

its Estimate Q2 for 65 Days of $ 0,8 Mn was not achieved and therefore

it becomes difficult to use the numbers for calculations !


- Florida Project of Revenue $ 800,000 , where TRTC get a Royalty of 15%,

the complain for after the first Business- Year to increase this also to 20%

is made to TRTC, but since there is not yet any TRTC reconfirmation we

need to calculate this by the Royalty of 15% !



- For the Hydroponic Equipments & Accessories & Companies Sales

we have not any reliable Estimate Numbers and need to wait until

the next Version of Investors Presentation.

Therefore at the moment we cannot consider this !



- For TRTC’s Electricity Management Matter we have also No Numbers

until now and therefore cannot consider this !



This Above Points 1. and 2. As Calculation Basis !!





According to Above and to make it a little more simple,

the Calculation Estimates of Revenue, Earnings and

Stock- Price only as from 2014 :



- New 5-Acre Production Plant, Revenue $ 9 Mn, Earning $ 3,6 Mn !



- NB Plants & GroRite Contracts, Revenue $ 7 Mn, Earning $ 0,7 Mn !



- Florida Project, Revenue $ 0,8 Mn, Earning $ 0,12 Mn !

( Here Without New Such Projects TRTC Announced For US Wide ! )



- Hydroponic Equipments & Accessories & Complete Companies Sales also

under Contracts for Edible Garden Products as in Florida, here not considered !



- The TRTC’s Electricity Management Matter, here not considered !



( Here Without Any MJ or Hemp Growing Projects Soon Possible ! )



As Resulting :

2014 Revenue Estimate = $ 16,8 Mn

2014 Earning Estimate = $ 4,42 Mn



TRTC Stock- Price = $ 1,99 at for example 100 Mn Stocks by EPS- Ratio 45x !!

This within the first 6 Months of 2014, depending on TRTC Progress

Information’s and the resulting Investors Reactions !!



At during 2012 until Q1 2013, the Monthly Money Net- Loss

was at $ 0,5 Mn and this now by 50% Less has improved !.

At Same Rate TRTC Will Be Writing Black- Profit Numbers

Already As From Within November 2013 !!


3. If TRTC by the US Fed. would be allowed to grow MJ or TRTC does

Grow the Gene Manipulated CBD Hemp with ZERO THC as already by

the US Senate as Industrial Agricultural Product Is US Wide Legalized,

it compare the Bio·Vegetable & Herbs could provide a 7 - 10x Higher

Profit- Margin resulting the Stock- Price of $ 1,99 to increase 6 - 8x !!



To use possibly Morphine- Based Medication with Huge- Side- Effects only

for Last Days of Life, because CBD can replace over 90 % of Morphine

Applications !

For TRTC because there is no other same US company existing it means

also, if GW Pharmaceuticals owned by the Big Companies Consortium of

worldwide annual Revenues $ 160 Bn is deciding to have Production of

CBD Sativex also in the US as well for Latin America Markets, it could by

TRTC in US get the Gene Manipulated CBD Hemp produced Hydroponically

Free Of Very Toxic Pesticides, instead now just everything Europe Made !!



Depending on US MJ Laws, TRTC has the Big Potential to become

„King of Marijuana“ because has the capacity to produce the MMJ

in the Best Med. Bio-Quality for the complete US Demand without

Very Toxic Pesticides as by any other much smaller producers !!

This By TRTC‘s Office for MJ & CBD Marketing In Washington !

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

TCTM KIDS IT Education Inc. Announces 2024 Annual Report

Updated Category News Views 322

TCTM KIDS IT Education Inc. Issues 2024 Annual Report TCTM KIDS IT EDUCATION INC. (NASDAQ: VSA), a prominent leader in IT-focused supplementary STEM education, has officially filed its annual report on Form 20-F for the fiscal year ending December 31, 2024, with the Securities and Exchange Commission (SEC). This filing reflects the company’s ongoing commitment to...

Continue Reading
Polaris Celebrates Commitment to Community and Environment

Updated Category News Views 224

Polaris Revolutionizes Commitment Through Geared For Good Report Polaris continues to ensure sustainability and responsible stewardship across its operations, supporting its employees, riders, communities, and the environment. The recently released report illustrates Polaris Inc.'s (NYSE: PII) dedication to these values. Impacting Lives Through Corporate Responsibility...

Continue Reading
AgentCoach.AI Transforms Real Estate Coaching with AI Tools

Updated Category News Views 195

AgentCoach.AI Revolutionizes the Coaching Landscape Real Estate Professionals Gain Access to On-Demand Expertise and Tools for a Fraction of Traditional Coaching Costs AgentCoach.AI is excited to introduce its innovative AI-powered coaching platform tailored specifically for real estate agents. This groundbreaking service is designed to streamline everyday tasks, enhance...

Continue Reading
Unleash Creativity: LEGO's 2025 Workshop Series for Kids

Updated Category News Views 460

LEGO Group Launches Exciting 2025 Creativity Workshop Series The LEGO Group is thrilled to introduce its innovative 2025 Creativity Workshop Series, offering young creators a fantastic opportunity to unleash their imagination. Tailored for children aged 6 to 12, these engaging workshops will take place at select LEGO stores, providing both in-person and online...

Continue Reading
Kering Overview: Enhanced Share Liquidity Insights for Growth

Updated Category News Views 132

Kering Overview: Enhanced Share Liquidity Insights for Growth Kering has recently shared a detailed report on its share liquidity mandate which outlines the company's achievements during the first half of the year. This report sheds light on the performance and trading activity of Kering shares as per its engagement with Rothschild Martin Maurel. There is an evident...

Continue Reading